
    
      Subjects with a previous diagnosis of asthma will be pre screened within 90 days prior to
      enrolment. If a subject develops symptoms of human rhinovirus (HRV) infection they will visit
      the site for assessment. Symptomatic subjects meeting all eligibility criteria will be
      invited to enroll.
    
  